Neurofeedback improves executive functioning in children with autism spectrum disorders

Kouijzer, Mirjam E.J.; Moor, J.M.H. de; Gerrits, Berrie J.L.; Congedo, Marco; Schie, Hein T. van

doi:10.1016/j.rasd.2008.05.001

Cited by 112 publications

(102 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Participants of the present study were the same as in our earlier study (Kouijzer et al, 2009) and consist of fourteen children with ASD (12 males; 2 females) with a mean age of 10.1 years (range 8-12 years). All children had an IQ-score of 70 and above and a diagnosis of ASD (subtype pervasive developmental disorder-not otherwise specified, PDD-NOS), according to the criteria of DSM-IV conferred by a child psychiatrist or licensed psychologist.…”

Section: Participantsmentioning

confidence: 99%

“…Maintenance of benefits of neurofeedback treatment would be demonstrated if, firstly, no significant decrease in performance is found between follow-up and post-assessment. Second, a comparison between follow-up and preassessment was made in order to confirm the significant effects of neurofeedback treatment in ASD in line with Kouijzer et al (2009). No significant changes were expected in QEEG, since no significant differences between pre-and post-assessment were found in our earlier study.…”

mentioning

confidence: 91%

“…Recently, follow-up data after 6 months was reported by Leins et al (2007). In a recent study, we reported the results of neurofeedback treatment in children with autism spectrum disorders (ASD) as compared to a waiting list control group (Kouijzer, De Moor, Gerrits, Congedo, & Van Schie, 2009). Treatment consisted of 40 sessions of neurofeedback and included inhibition of theta activity (4-7 Hz) and rewarding low beta activity (12-15 Hz) over the right hemisphere.…”

mentioning

confidence: 99%

“…A follow-up after three months revealed maintenance of the described outcomes on both executive functioning and social behavior. See Kouijzer et al (2009) for detailed explanation of the improvement in executive functioning and for an explanation of the tasks that were used.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Autism Spectrum Disorders

Engeland¹,

Buitelaar²

2008

Rutter's Child and Adolescent Psychiatry

View full text Add to dashboard Cite

In the evaluation of any treatment, it is extremely important to gather information about the longlasting effects of treatment by collecting follow-up data. Follow-up research aims to measure effects of treatment over time to determine if the treatment has resulted in a structural improvement or if clients relapsed to pre-assessment levels. The importance of follow-up data for the evaluation of neurofeedback has been noted repeatedly. Heinrich, Gevensleben, and Strehl (2007), for example, suggest investigation of clinical outcomes, spectral EEG analysis, and neuromodulatory skills using at least a 6-month follow-up interval. Despite many recommendations, the use of follow-up in evaluating neurofeedback as a treatment for several disorders has been used only in a few studies. In Previously we demonstrated significant improvement of executive functions and social behavior in children with autism spectrum disorders (ASD) treated with 40 sessions of EEG neurofeedback in a nonrandomized waiting list control group design. In this paper we extend these findings by reporting the long-term results of neurofeedback treatment in the same group of children with ASD after 12 months. The present study indicates maintenance of improvement of executive functions and social behavior after 12 months in comparison with the immediate outcomes. Neurofeedback mediated suppression of theta power is supposed to promote more flexible functioning of the brain by enhancing activation in the medial prefrontal cortex and improving flexibility of activation in the default mode network supporting the improvement of executive functions and theory of mind in ASD. ß

show abstract

Section: Participantsmentioning

confidence: 99%

mentioning

confidence: 91%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Autism Spectrum Disorders

Engeland¹,

Buitelaar²

2008

Rutter's Child and Adolescent Psychiatry

View full text Add to dashboard Cite

show abstract

“…Neurofeedback has also been shown to significantly improve executive functioning and working memory. 47,48 By improving regulatory capabilities and executive functions, neurofeedback may provide a crucial buffer against relapse, which has been linked to impaired executive functions such as working memory. 11,49 In addition, neurofeedback training may promote a more relaxed state and lead to better perceived control of stress, thereby addressing another key factor in relapse prevention.…”

mentioning

confidence: 99%

The Progression of Neurofeedback: An Evolving Paradigm in Addiction Treatment and Relapse Prevention

Sunder¹,

Bohnen²

2017

MOJAMT

View full text Add to dashboard Cite

Abbreviations: TOVA, test of variables of attention; MMPI, minnesota multiphasic personality inventory; cAMP, cyclic adenosine monophosphate; CREB, camp response element binding protein; MCI, mild cognitive impairment Introduction Recognizing addiction as a public health crisisA recent report published by the Center for Behavioral Health Statistics and Quality found that approximately one in seven Americans is expected to develop a substance use disorder at some point in their lives.1 In 2015, 20.8 million people aged 12 or older in the United States had a substance abuse disorder, indicating that the number of Americans suffering from addiction is similar to the number of Americans suffering from diabetes.2 Moreover, the prevalence of substance use disorders is nearly 1.5 times that of all cancers combined. 3In 2014, over 47,000 people died from a drug overdose. This figure includes nearly 30,000 people who died from an overdose involving prescription drugs, which is more than in any previous year on record. Heroin overdoses have more than tripled between 2010 and 2014. 4 Alcohol misuse, which contributes to 88,000 deaths per year in the United States, was found to be the nation's fourth leading preventable cause of death. 5,6 Approximately one in ten deaths among working adults in the United States is caused by alcohol abuse. 5 The health care expenses, lost productivity, and criminal justice costs related to substance abuse are estimated to cost the federal government $442 billion dollars each year. 7,8 In response to this public health crisis, the U.S. Surgeon General published a report declaring that addiction must be approached as a chronic illness, alongside conditions such as heart disease, diabetes, and cancer. Current issues in addiction treatment and relapse preventionAddiction is characterized by improper engagement of the systems involved in adaptive decision-making.10 Deficiencies in executive functions such as working memory allow substance use behavior to be guided more strongly by automatic, impulsive processes.11 Genetic polymorphisms or stress may induce a hypodopaminergic trait/state, predisposing individuals to instinctively seek out substances or behaviors that stimulate dopaminergic activity.12,13 Substance use may thus engage a vicious cycle, as addictive drugs have been implicated to damage brain regions involved in higher-order functioning, further reducing self-regulatory capabilities.14 Although traditional methodologies such as counseling, group therapy, and medication have produced some success in treating addiction, relapse rates remain high. Bailey et al. reported that 90% of inpatient opioid detoxification patients relapsed within a year of treatment.15 A key factor accounting for the likelihood of relapse among addiction patients may be the persistence of aberrant neurobiological changes affecting reward prediction and motivation. It is plausible that traditional therapies may only address maladaptive patterns of synaptic connectivity to a limited extent, preserving some aberra...

show abstract